Table 1.
Experimental Mouse Group | Number | Immunosuppressed | Ureaplasma parvum challenge | Positive culture | P value* | ||
---|---|---|---|---|---|---|---|
Blood | Lung | Peritoneal cavity swab | |||||
Normal control (immunocompetent, uninfected) | 12 | No | No | NA | NA | NA | 0.16 |
Immunosuppressed control | 12 | Yes | No | 0 | 0 | 0 | 0.42 |
IT/IP challenged immunocompetent control | 12 | No | Yes | 0 | 6 | 5 | 0.47 |
Vehicle IT/IP negative control1 | 16 | Yes | Spent broth | 0 | 0 | 0 | Reference |
IT/IP challenge2 | 19 | Yes | Yes | 0 | 13 | 9 | 0.0008 |
IP challenge3 | 20 | Yes | Yes | 0 | 0 | 8 | <0.0001 |
IT, intratracheal; IP, intraperitoneal; NA, not applicable
P value for ammonia concentrations compared to spent vehicle broth
Two deaths prior to experimental endpoint (days 10 and 12), attributed to anesthesia and IT challenge.
Eight deaths prior to experimental endpoint. One mouse died on day 11 after having been noted to feel cool to touch. One mouse developed bladder enlargement and died after immunosuppressive drug administration on day 11; it was not possible to assess its ammonia level but blood and bladder aspirate cultures were positive. One mouse was sacrificed on day 11 because of tachypnea, hunched stature and lethargy; cultures of blood, lung and a peritoneal swab were positive and ammonia was 955 μmol/L. Four mice died after IT/IP inoculation on day 12, of which two developed an enlarged bladder and died about 15 minutes after IT/IP inoculation with ammonia levels >1000 μmol/L and positive blood and bladder aspirate cultures. One mouse was sacrificed on day 12 because of tachypnea, hunched stature and lethargy; cultures of lung and a peritoneal swab were positive and ammonia was 326 μmol/L.
One death just before sacrifice on day 14; the animal had hunched stature and lethargy after inoculation on day 13.